Two pharmacists have received suspended prison sentences after admitting to illegally supplying vast quantities of controlled drugs in a case described as operating on an “industrial scale.” The convictions follow a detailed investigation by the Medicines and Healthcare Products Regulatory Authority (MHRA) Criminal Enforcement Unit.
Sentencing Details
Mandip Sidhu, 47, from Littleover, Derby, and Nabeil Nasr, 42, from Cheadle, Greater Manchester, were each sentenced to two years in prison, suspended for 24 months, by Southwark Crown Court.
- Sidhu was convicted on five counts, including the supply of Class C drugs and forgery.
- Nasr faced charges related to supplying Class C drugs and wholesale dealing without a licence.
Scale of Offences
The offences, committed between May 2013 and June 2017, involved the illegal supply of more than 55 million doses of Class C drugs, with diazepam alone accounting for over 47 million doses.
Sidhu, as director of Pharmaceutical Health Limited (PHL) in Derby, purchased vast quantities of drugs despite the company ceasing to dispense medicines against prescriptions in July 2013. Nasr, who owned multiple pharmacies in northwest England, was also implicated in the large-scale illegal distribution.
Forgery and Deception
In addition to supplying controlled drugs, Sidhu pleaded guilty to forgery. He fabricated an invoice in an attempt to mislead an MHRA inspector, showcasing the deliberate and deceptive measures taken to conceal their illicit operations.
MHRA Response
Andy Morling, MHRA Deputy Director of Criminal Enforcement, praised the investigation team, stating:
“This case highlights the exceptional dedication and professionalism of MHRA staff. We remain committed to using all available resources to protect the public from the harmful effects of illicit drug trading.”
The MHRA emphasized that stringent regulatory measures are critical in preventing abuses within the pharmaceutical industry. Both Sidhu and Nasr operated without the necessary licences, blatantly disregarding legal and ethical obligations.
Industry and Public Safety Concerns
This case serves as a stark reminder of the potential risks posed by unlawful practices in the pharmaceutical sector. The scale of the operation, which facilitated the illegal circulation of millions of controlled drug doses, underscores the need for vigilant oversight and enforcement to safeguard public health.
Conclusion
The sentencing of Sidhu and Nasr demonstrates the severe consequences for those who breach pharmaceutical regulations and engage in criminal activities. The MHRA’s continued efforts to uphold legal standards within the industry aim to prevent similar abuses and ensure the safety of the public.
